港鐵(00066.HK)獲深圳市軌道交通13號線公私合營招標項目
港鐵(00066.HK)宣布,其全資擁有的港鐵技術諮詢牽頭夥拍中鐵電氣化局,獲得深圳市軌道交通13號線公私合營項目中標通知書,下一步將與深圳市政府簽署協議,對項目進行投資、建設及為期30年的營運。
相關的公私合營項目會由新成立的合資公司投資經營,而港鐵諮詢與中鐵電氣化局分別佔該合資公司的83%及15%股權,其餘2%權益將由深圳市政府的附屬公司持有。是次的公私合營項目將涵蓋車輛、信號、自動售檢票系統等機電設備及鋪軌工程,總投資額約49.1億元人民幣,將以貸款及股本形式投資。
至於13號線的土建工程部分,則由深圳市地鐵集團負責出資建設。13號線建成後將會是深圳中部地區南北向骨幹線,全長約22.4公里,設有16個車站,初步預計於2023年投入服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.